Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Monty Goldin

M. Goldin, MRPharmS

Recent stories

  • Treating diabetes patients requires more than drugsSubscription

    10 DEC 2015

    Pharmacists must realise that type 2 diabetes is not just about glycaemic control. There is more to treating and preventing the condition than throwing pills at patients. Each branch of medicine is now involved in treating type 2 diabetes, including dietitians, dermatologists, podiatrists and even psychiatrists. Do we know the psycho-socioeconomic status of our diabetes patients? Do we understand the ominous octet and the mechanism of gluconeogenesis? It seems we have a lot to learn to treat

  • The NHS is a customer, not something to saveSubscription

    3 FEB 2015

    Contrary to Graham Phillips’s view (The Pharmaceutical Journal 2015;294:116), I do not believe community pharmacy is going to save the NHS. The NHS is a customer. It buys services from community pharmacies which are businesses operating purely for profit. Ask the multiples, supermarkets and the merchant class that control vast areas

  • Medicinal cannabis widely used in IsraelSubscription

    2 DEC 2014

    I would like to add to David Nutt’s piece about medicinal cannabis (The Pharmaceutical Journal 2014;293:560). Cannabidiol and d9-tetrahydrocannabinol were discovered by scientists in Israel and medicinal cannabis is now widely used there for a number of conditions. It is grown in secret locations under strict security and is prescribed by doctors registered to do so. There is now a facility to grow

  • E-cigarettes in pharmaciesSubscription

    24 OCT 2014Comments (1)

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.